Common Reactions And Standardized Management Protocols Following Core Needle Biopsy

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

Core Needle Biopsy (CNB) is one of the gold standards for diagnosing breast lesions. Despite its minimal trauma and high precision, localized ecchymosis (hematoma) remains the most common post-operative complication. From a clinical management perspective, ecchymosis is not merely a simple "side effect" but a vital indicator for evaluating puncture technique, patient constitution, and the quality of post-operative care.

I. Etiology and Grading of Ecchymosis

Ecchymosis is essentially the result of microvascular rupture beneath the skin or within the glandular tissue. During CNB, regardless of whether 14G or 16G needles are used, the cutting and aspiration actions can damage the capillary network. Key factors influencing the severity of ecchymosis include:

1. Needle Characteristics:​ As previously discussed, stainless steel and titanium alloy needles possess different rigidities. Stiffer needles may generate greater shear force during advancement, increasing the risk of vascular injury. Additionally, diminished sharpness in disposable plastic needles may lead to repeated punctures.
2. Puncture Pathway:​ Transcutaneous punctures traversing areas with thin subcutaneous fat layers or prominent superficial vasculature significantly increase the probability of ecchymosis.
3. Patient Factors:​ Coagulation disorders, the use of anticoagulant medications (such as aspirin or warfarin), and low platelet counts can all exacerbate and enlarge ecchymosis.
4. Number of Passes:​ To acquire sufficient samples for molecular subtyping (e.g., ER, PR, HER2 testing), multiple passes (typically 4–6) are often required. Each pass constitutes secondary trauma to the tissue, and the cumulative effect leads to a larger ecchymosis area.

Clinically, ecchymosis can be graded into three levels:

• Mild:​ Localized bruising <2 cm in diameter, non-tender, resolving spontaneously within 24 hours.
• Moderate:​ 2–5 cm in diameter, accompanied by slight swelling and tenderness, requiring cold compress intervention.
• Severe:​ >5 cm in diameter, forming a palpable hematoma with severe pain; rarely, surgical drainage may be required.

II. Standardized Management Protocol

For ecchymosis following CNB, a "Three-Step" management protocol is recommended:

1. Immediate Compression:​ Apply firm pressure with a gauze roll to the puncture site for 5–10 minutes immediately after needle withdrawal. Studies indicate that continuous compression reduces the incidence of ecchymosis by 40% compared to intermittent pressure.
2. Alternating Hot and Cold Therapy:​ Apply an ice pack for the first 24 hours post-op (15 minutes per session, every 2 hours) to constrict blood vessels. Switch to warm compresses after 48 hours to promote the absorption of extravasated blood. Ensure a barrier exists between the pack and the skin to prevent frostbite or burns.
3. Dynamic Monitoring:​ Instruct patients to document changes in the ecchymosis size. If the bruise enlarges rather than shrinks within 72 hours, or if a pulsatile mass appears, active bleeding must be suspected. Immediate ultrasound examination is required to rule out a pseudoaneurysm.

III. Significance for Patient Education

Many patients experience anxiety due to concerns that ecchymosis will affect aesthetics or cause malignant transformation. Physicians should explicitly inform patients that ecchymosis resulting from CNB is a normal inflammatory response and does not increase the risk of tumor spread. In fact, moderate ecchymosis indicates that immune cells are gathering locally, which may help clear potential exfoliated cells within the needle tract. Establishing a standardized ecchymosis management protocol not only enhances patient satisfaction but also reduces unnecessary emergency department visits.